Shanghai Unionlab Co., Ltd (Unionlab) was founded in 2017. The headquartered based on Shanghai. Unionlab focuses on innovative oncology drug. We deliver an integrated service from the strategy to implementation, including Strategy Consultation, Medical Affairs, Clinical Study Operation, Third-party Independent Imaging Review, a Central Laboratory, Data Management, Bioanalysis, FSP and other service. Unionlab's mission is to provide an efficient clinical research service through the use of information-based, smart technology to satisfy the requirements of the clinical development of new drugs, rapid trial and error, dynamic decision-making, high quality, and low cost. Unionlab’s team member over 500. The Unionlab team has responsible for over dozens of clinical trial of innovation drugs, including Antibody, ADCs, micromolecule Targeted Therapies, and others.
Yaoyan Intelligent is the subsidiary company of Unionlab. Yaoyan Intelligent is a digitized, embedded SMO. Yaoyan Intelligent has independently developed a multicenter collaborative smart clinical research system (eDISC) and has helped clinical research centers increase their operation efficiency through AI, big data, and e-Cloud technology. eDISC is operating online in many centers from so far, and it is planned to be deliver it to 30+ hospitals and operating on networks in 2022. Through the layout of the system, we have gradually brought about the digital, smart, platform-based operation in the phase I expansion period of new drug and key clinical studies period. That make truly the faster, better and manageable costs in transform of new drug clinical trial.
Where did Unionlab originate from?
——The Doctrine of the Mean, Part 31
Unionlab was established
Provided medical and clinical operation services
Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of colorectal cancer
Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of malignant lymphoma
Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of advanced stomach cancer
Completed the first subject enrolment for a phase I study in the treatment of colorectal cancer.
Completed bioanalysis laboratory
Developed the IRC and patient recruitment service
Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of solid tumors
Signed a cooperation agreement with a sponsor to complete a pharmacokinetic clinical study
Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of malignant tumors
Developed data management and stats business
Signed the first IRC service project
Developed eDISC system
The big-data clinical research system clinIQ goes online
Signed the first CRO phase III service project
Launched the investigator meeting of whole country for phase III research in the treatment of HCC
The independent radiology review committee (IRC) system U-Orbit V1.0 goes online
Signed the first master service agreement for independent imaging review services for clinical trials
Signed an agreement for the first IRC service project (phase II follicular lymphoma, IRWG criteria)
The smart multicenter clinical research system, eDISC, is launched and implemented in a domestic leading research center for new drugs for early-stage tumors
The Guangzhou and Beijing branches are officially opened and runed
Signed the agreement for an NSCLC project. Signed the agreement for a phase III TNBC project, For the first time the phase III project has been completed. Clinical Research Center Training. Image review specialist training, Union Image provides its first batch of phase III deliverable documents to a sponsor.
Signed a cooperation agreement with a sponsor to complete a phase III study in the treatment of HCC. Signed a cooperation agreement with a sponsor to complete a phase II study in the treatment of SCCHN. Signed a contract for a phase Ib/II gastric or GEJ adenocarcinoma project.
The clinical monitoring time management system Time Sheet V1.0 goes online
Signed the agreement for a phase III NSCLC project. The Smart Technology Driven Oncological Clinical Trial Process Workshop and 2019 Fourth Quarter Zhangjiang Life Sciences Conference is successfully held.
eDISC system is delivered in the first center to carry out SMO service
Signed a cooperation agreement with a sponsor to complete a phase III study in the treatment of HCC. Signed the agreement for the phase III NSCLC project. This project is the first in which Union Image used the Dual Oncological Evaluation Criteria.
Independent radiology review committee (IRC) system U-Orbit V1.1 goes online
Successfully received ISO 9001 quality management system certification
Signed a cooperation agreement with a sponsor to complete a phase II study in the treatment of HCC. Signed a cooperation agreement with a sponsor to complete a phase I study in the treatment of advanced solid tumors.
Expanded laboratory business
Developed FSP service
Complete the round A financing of more than 100 million
Acquisition of START
Completed system delivery of multiple centers
Complete the round A+ financing of more than 100 million
Unionlab make the very solid cooperation with over 10 domestic core PI in oncology, including liver cancer, breast cancer, pancreatic cancer, head and neck cancer, stomach cancer, intestinal cancer, lung cancer, hematological tumor and others.
Unionlab has established a team of over 50 senior image review specialists from hospitals specializing in grade 3A cancer. They have a rich experience in reviewing images from new drug clinical trials for pharmaceutical companies with domestic and MNC. The team members have all been able to undergo serial induction training and pre-enrolment directed training.
The smart clinical trial system has been delivered to numerous centers and has been operation.
Unionlab has been make the cooperation with 260 investigators and cover 200 clinical research centers, distribute 54 cities in China.
There are 11 hospitals in the US that we have been built the cooperation.